Marketgems Earnings Trader- Trading Strong or Weak Earnings Growth

[Profit_Ace]

AGIX! appears to be starting its pre-announcement run. The date is not fixed and is speculated to come at the end of Sept. or the lst week of Oct. AGIX has AGI-1067, a drug derived from an existing drug, Probucol, a cholesterol lowering med which is now defunct becoz of arrythmia causing side effects. Scientists were able to modify the Probucol molecule to beget AGI-1067. lst phase trial demonstrated the unique property of reducing plaque in arteries. This 2nd phase trial hopes to determine the extent and significance and it is this result we are awaiting with bated breath. A 3rd phase is already underway to determine whether AGI-1067 would reduce mortality and morbidity. MGT must be very confident to begin this phase even before the 2nd phase outcome is known.

Bottomline: Best play is to buy the October calls (like 22.5 or 25) and buy a 1/2 position of puts (17.5 or 15). The odds at this point strongly favor a favorable outcome. AGIX will either rocket to 40+ or shrink to 10-.

Pls do your own DD